UBS Maintains Buy on Scotts Miracle Gro, Raises Price Target to $77
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and raises the price target from $70 to $77.
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and raises the price target from $70 to $77.